1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Status Migrainosus: new trials by email Literature Review of Status Migrainosus trials Research Report on Status Migrainosus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Intravenous Erenumab in Patients With Status Migrainosus Erenumab - Status Migrainosus | Phase 1 | Withdrawn | Mayo Clinic | 2021-09-07 | 2022-02-22 |
Brain Diseases (1) · Central Nervous System Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Nervous System Diseases (1)
erenumab (1)
Mayo Clinic (1)
United States (1)